← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neorx Corporation
Seattle, WA
$1,723,394
Total funding
4
Grants
Funding mix
By agency
NIH$1,723,394 · 4
By mechanism
R44$1,514,682 · 2
R43$108,679 · 1
R41$100,033 · 1
Investigators at Neorx Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
PRETARGETED RIT TO TREAT NON-HODGKIN'S LYMPHOMA$725,196
R44 · FY2001 · CA
PRETARGETED RIT TO TREAT NON-HODGKIN'S LYMPHOMA$358,187
R44 · FY2002 · CA
ALPHA RADIOTHERAPY VIA PRETARGETED LEAD 212$314,561
R44 · FY2001 · CA
GEMCITABINE POTENTIATION OF PRETARGET RIT$108,679
R43 · FY2001 · CA
PRETARGETED RIT TO TREAT NON-HODGKIN'S LYMPHOMA$104,167
R44 · FY2000 · CA
MELANOMA RADIOTHERAPY- PEPTIDE TARGETED ALPHA-RADIATION$100,033
R41 · FY2000 · CA
ALPHA RADIOTHERAPY VIA PRETARGETED LEAD 212$12,571
R44 · FY2000 · CA